SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001104659-15-082661
Filing Date
2015-12-03
Accepted
2015-12-03 12:28:59
Documents
7
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q/A a15-23087_110qa.htm 10-Q/A 77677
  Complete submission text file 0001104659-15-082661.txt   4091934

Data Files

Seq Description Document Type Size
2 XBRL INSTANCE DOCUMENT acrs-20150930.xml EX-101.INS 1041403
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT acrs-20150930.xsd EX-101.SCH 47889
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT acrs-20150930_cal.xml EX-101.CAL 39408
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT acrs-20150930_def.xml EX-101.DEF 167261
6 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT acrs-20150930_lab.xml EX-101.LAB 443471
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT acrs-20150930_pre.xml EX-101.PRE 308666
Mailing Address SUITE 400, 101 LINDENWOOD DRIVE MALVERN PA 19355
Business Address SUITE 400, 101 LINDENWOOD DRIVE MALVERN PA 19355 484-321-5554
Aclaris Therapeutics, Inc. (Filer) CIK: 0001557746 (see all company filings)

IRS No.: 460571712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-37581 | Film No.: 151266747
SIC: 2834 Pharmaceutical Preparations